NCT02823327 · OUTCOME
Survival Status at 2 Years
Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma · Source last updated 2025-05-11
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- At 2 years post diagnosis
What was measured
Survival duration will be determined using the elapsed time between the date of PEL diagnosis and the last follow-up date or the date of death.
Analysis population: There are 8 participants with survival less than 2 years and 17 participants with survival more than or equal to 2 years.
Groups in this outcome
Survival Less Than 2 Years
Survival status at 2 years was determined using medical chart review for 25 participants. There were 8 participants with survival less than 2 years.
Survival More Than or Equal to 2 Years
Survival status at 2 years was determined using medical chart review for 25 participants. There were 17 participants with survival more than or equal to 2 years.
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
| Group | Source count |
|---|
| Survival Less Than 2 Years | 8 |
|---|
| Survival More Than or Equal to 2 Years | 17 |
|---|
Reported measurements
Hispanic
Values in participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Survival Less Than 2 Years | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Survival More Than or Equal to 2 Years | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
Non-Hispanic
Values in participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Survival Less Than 2 Years | 6 | Not reported | Not reported | Not reported | Not reported |
|---|
| Survival More Than or Equal to 2 Years | 12 | Not reported | Not reported | Not reported | Not reported |
|---|
White
Values in participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Survival Less Than 2 Years | 5 | Not reported | Not reported | Not reported | Not reported |
|---|
| Survival More Than or Equal to 2 Years | 9 | Not reported | Not reported | Not reported | Not reported |
|---|
Non-White
Values in participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Survival Less Than 2 Years | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
| Survival More Than or Equal to 2 Years | 8 | Not reported | Not reported | Not reported | Not reported |
|---|
EPOCH treatment
Values in participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Survival Less Than 2 Years | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Survival More Than or Equal to 2 Years | 13 | Not reported | Not reported | Not reported | Not reported |
|---|
Non-EPOCH treatment
Values in participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Survival Less Than 2 Years | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Survival More Than or Equal to 2 Years | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
Stage I-III
Values in participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Survival Less Than 2 Years | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Survival More Than or Equal to 2 Years | 6 | Not reported | Not reported | Not reported | Not reported |
|---|
Stage IV
Values in participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Survival Less Than 2 Years | 6 | Not reported | Not reported | Not reported | Not reported |
|---|
| Survival More Than or Equal to 2 Years | 11 | Not reported | Not reported | Not reported | Not reported |
|---|
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 2
- group Id
- OG001
- value
- 5
- title
- Hispanic
- categories
- measurements
- group Id
- OG000
- value
- 6
- group Id
- OG001
- value
- 12
- title
- Non-Hispanic
- categories
- measurements
- group Id
- OG000
- value
- 5
- group Id
- OG001
- value
- 9
- title
- White
- categories
- measurements
- group Id
- OG000
- value
- 3
- group Id
- OG001
- value
- 8
- title
- Non-White
- categories
- measurements
- group Id
- OG000
- value
- 4
- group Id
- OG001
- value
- 13
- title
- EPOCH treatment
- categories
- measurements
- group Id
- OG000
- value
- 4
- group Id
- OG001
- value
- 4
- title
- Non-EPOCH treatment
- categories
- measurements
- group Id
- OG000
- value
- 2
- group Id
- OG001
- value
- 6
- title
- Stage I-III
- categories
- measurements
- group Id
- OG000
- value
- 6
- group Id
- OG001
- value
- 11
- title
- Stage IV
- denoms
- counts
- group Id
- OG000
- value
- 8
- group Id
- OG001
- value
- 17
- units
- Participants
- description
- Survival duration will be determined using the elapsed time between the date of PEL diagnosis and the last follow-up date or the date of death.
- groups
- description
- Survival status at 2 years was determined using medical chart review for 25 participants. There were 8 participants with survival less than 2 years.
- id
- OG000
- title
- Survival Less Than 2 Years
- description
- Survival status at 2 years was determined using medical chart review for 25 participants. There were 17 participants with survival more than or equal to 2 years.
- id
- OG001
- title
- Survival More Than or Equal to 2 Years
- param Type
- NUMBER
- population Description
- There are 8 participants with survival less than 2 years and 17 participants with survival more than or equal to 2 years.
- reporting Status
- POSTED
- time Frame
- At 2 years post diagnosis
- title
- Survival Status at 2 Years
- type
- PRIMARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle